SEC Form 4 · accession 0001493152-17-003329
ONCOSEC MEDICAL Inc · ONCS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Punit Dhillon
Officer — President and CEO · Director
Period of report
Mar 29, 2017
Accepted (ET)
Mar 31, 2017 · 9:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444307
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Mar 29, 2017 | A | 150,000 | A | Mar 29, 2020 | Mar 29, 2020 | Common Stock | 150,000 | 275,000 | D |
| Option to Purchase Common StockF3 | $1.34 | Mar 29, 2017 | A | 150,000 | A | Mar 29, 2017 | Mar 29, 2027 | Common Stock | 150,000 | 564,583 | D |
Explanation of responses
- F1Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- F2100% of the restricted stock units are scheduled to vest on March 29, 2020, assuming continued employment and/or service through the applicable vesting date.
- F325% vested on the Grant Date, and the remaining 75% to vest in 36 equal monthly increments, beginning on the first monthly anniversary of the Grant Date, pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan.